We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals

hedge funds and large institutions have $1.3M invested in Tonix Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% less capital invested

Capital invested by funds: $2.79M → $1.3M (-$1.49M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $5K

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$5K
Net Calls
-$5K
Net Calls Change
+$111K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$364K
KCM
2
Kingdon Capital Management
New York
$327K
Vanguard Group
3
Vanguard Group
Pennsylvania
$250K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$47K
Goldman Sachs
5
Goldman Sachs
New York
$46K
Morgan Stanley
6
Morgan Stanley
New York
$40K
RHBC
7
R.H. Bluestein & Co
Michigan
$36K
FMA
8
FNY Managed Accounts
New York
$35.3K
OC
9
Oppenheimer & Co
New York
$34K
BFA
10
BlackRock Fund Advisors
California
$28K
BIT
11
BlackRock Institutional Trust
California
$22K
Northern Trust
12
Northern Trust
Illinois
$16K
VKH
13
Virtu KCG Holdings
New York
$10K
Bank of New York Mellon
14
Bank of New York Mellon
New York
$8K
CS
15
Credit Suisse
Switzerland
$7K
State Street
16
State Street
Massachusetts
$7K
CG
17
Cutler Group
California
$5K
Group One Trading
18
Group One Trading
Illinois
$5K
KA
19
Klingman & Associates
New York
$5K
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$5K
BIM
21
BlackRock Investment Management
Delaware
$2K
UBS Group
22
UBS Group
Switzerland
$2K
BA
23
BlackRock Advisors
Delaware
$1K
Creative Planning
24
Creative Planning
Kansas
$1K
BCM
25
Bridgeway Capital Management
Texas
-$66K